Single-Stock ETFs

What they are

Three variants dominate:

• Leveraged single-stock (2x a named company's daily return), built with swaps and options.
• Inverse single-stock (−1x or −2x daily), for expressing a bearish view without a margin account or borrow.
• Option-overlay single-stock (covered-call on one company), promising eye-catching yields by selling upside on a volatile stock: Chapter 80's trade-off applied to a concentrated position.

All reset daily. All hold derivative exposure rather than large physical positions. All carry fees well above index products, commonly around 1%.

The arithmetic, at single-stock volatility

Chapter 74 established that volatility decay scales with volatility squared and with leverage. A broad index runs at roughly 15–20% annualised volatility. A large individual technology stock frequently runs at 40–60%, and around earnings it spikes far higher.

Put those numbers into the same machinery and the result is stark: the decay term that costs a 2x index fund a modest amount per year can cost a 2x single-stock fund a multiple of that, purely from the path. A stock that ends the quarter unchanged, having oscillated violently on earnings and news, can leave a 2x product on it down double digits, with nothing having gone wrong.

Then add the risk the leverage sits on top of: single-company risk, which Chapter 18 documented as the risk most likely to be permanent. Bessembinder's finding: that the median stock underperforms Treasury bills over its life, and that a small minority produce all the market's excess wealth: describes the unleveraged base case. A 2x product on a company that permanently declines does not merely track that decline; it amplifies it while decaying.

Why they exist

Not a rhetorical question: the answer explains the category:

Demand for leverage without a margin account. A retail trader wanting 2x exposure to a stock traditionally needed margin, options, or a CFD. A single-stock ETP delivers it in an ordinary brokerage account, with the maximum loss bounded at the amount invested (no margin call), which is a genuine feature relative to margin borrowing.

Access where shorting is hard. Inverse products let a holder express a bearish view without locating a borrow or facing recall risk.

Product economics. These carry high fees and attract high turnover. For issuers, that is a good business; the launch wave following the first US approvals was not driven by investor demand alone.

The bounded-loss point deserves credit where due: an investor who would otherwise use margin or naked options faces worse tail outcomes than a single-stock ETP holder. The honest framing is that these are a less-dangerous form of a dangerous activity, not a safe form of investing.

The regulatory reception

The US approvals in 2022 produced an unusual spectacle: SEC commissioners publicly expressing concern about products their own agency was permitting, warning that these were unsuitable for the retail investors most likely to buy them and questioning whether the ETF label itself was misleading in this context. FINRA has issued repeated reminders about suitability obligations and complex products.

The concern is specific and worth stating precisely: the wrapper carries an implicit promise it does not deliver here. Two decades of financial education, including this book's Part I, taught people that an ETF means diversification and long-term suitability. A product that inverts both while wearing the same three letters exploits that trained expectation. That is a labelling problem, not merely a risk-disclosure problem, and disclosure does not fully solve it.

Where they can be used legitimately

Stated fairly:

• Intraday and multi-day tactical positioning by someone who understands the daily reset, has a defined exit, and sizes for total loss.
• Hedging a concentrated exposure: an employee with a large restricted holding using an inverse product for a defined period is doing genuine risk management (Chapter 42's best-use logic), though options are often the more precise tool.
• Capital-efficient expression where the alternative is margin borrowing with its call risk.

For each, the horizon is short, the exit is written, and the position is small. Every one of those conditions is violated by the typical purchase.

Where they must not go

• Any long-term portfolio, core or satellite. Chapter 61's satellite framework assumes positions whose multi-year behaviour is knowable; these are path-dependent instruments layered on the least predictable single input available.
• Retirement accounts, where the horizon is by definition long.
• A "high-conviction" allocation. Conviction about a company is an argument for owning the stock, at a size you can hold. Adding daily-reset leverage converts a view about a business into a bet on a path.

A worked example

A stock ends the quarter exactly where it started, having risen 18%, fallen 22%, risen 15% and fallen 12% along the way: an ordinary quarter for a volatile large-cap.

• The stock: 0%.
• A 2x daily product on it: compounding each move at twice the rate produces roughly −9%, before its ~1% annual fee and financing costs.
• A −1x product: roughly −4%, having been positioned against a stock that went nowhere.
• The investor's likely explanation: "the product doesn't work properly."
• The actual explanation: the product delivered precisely 2x (or −1x) every single day, as documented on page one of its prospectus.

Nothing here is hidden. It is arithmetic that most buyers have never done, wrapped in three letters that two decades of financial education taught them to associate with prudence.